Ultragenyx Pharmaceutical Inc. (FRA:UP0)
20.20
0.00 (0.00%)
At close: Jan 30, 2026
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of €1.95 billion as of January 30, 2026. Its market cap has decreased by -46.91% in one year.
Market Cap
1.95B
Enterprise Value
2.31B
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
€20.20
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from 909.66M to 1.95B, an increase of 114.49%. That is a compound annual growth rate of 6.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.95B | 3.42% |
| Dec 31, 2025 | 1.89B | -49.69% |
| Dec 31, 2024 | 3.75B | 5.56% |
| Dec 29, 2023 | 3.55B | 16.88% |
| Dec 30, 2022 | 3.04B | -39.70% |
| Dec 31, 2021 | 5.04B | -32.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.14B |
| Sedlmayr Grund und Immobilien AG | 939.90M |
| Berliner Effektengesellschaft AG | 879.96M |
| Maschinenfabrik Berthold Hermle AG | 835.00M |